| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,850.10
|
|
Change (%)
|
35.15 (1.94%)
|
|
Best Buy (RS)
|
1847.8(x32)
|
|
Best Sell (RS)
|
1849.35(x293)
|
|
Today's Range (RS)
|
1,797.30
-
1,850.20
|
|
52-Week Range (RS)
|
571.00
-
1,828.85
|
|
Beta (1 Year)
|
0.36
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap, BSE IPO |
| News |
|
Corporate Details |
| Rubicon Research rallies as Q1 PAT soars 95.8% YoY |
| Rubicon Research consolidated net profit rises 95.80% in the June 2026 quarter |
| Rubicon Research schedules board meeting |
| Rubicon Research schedules AGM |
| Rubicon Research board approves merger with subsidiary |
| Rubicon Research allots 1.49 lakh equity shares under ESOS |
| Rubicon Research fixes record date for final dividend |
| Rubicon Research receives two procedural observations after USFDA inspection |
| Rubicon Research spurts after reporting strong Q4 performance |
| Board of Rubicon Research recommends final dividend |
|
|
|
| Incoporation Year : 1999 |
| Chairman : CHANGAVALLI VENKAT |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Rubicon Research Ltd
Medone House B-75 Road No.33,
Wagle Estate,
Thane (West),
Maharashtra-400604 |
Phone:022 6141 4000
Fax: |
| E-Mail : investors@rubicon.co.in |
| URL : http://www.rubicon.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
19-Aug-2026 |
1797.75 |
0.96 |
| 1Month |
27-Jul-2026 |
1562.25 |
16.18 |
| 3Month |
26-May-2026 |
977.40 |
85.69 |
| 6Month |
26-Feb-2026 |
787.10 |
130.59 |
| 1Year |
16-Oct-2025 |
627.45 |
189.26 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Kotak Mid Cap Fund |
0.81 |
563.36 |
| Motilal Oswal Small Cap Fund |
4.43 |
336.65 |
| Bajaj Finserv Flexi Cap Fund |
1.83 |
149.94 |
| Kotak Manufacture in India Fund |
4.21 |
124.20 |
| Bajaj Finserv Small Cap Fund |
4.09 |
96.63 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,916.10 |
0.57 |
5,249.95 |
3,480.00 |
185,923.81 |
| Gland Pharma Ltd |
2,891.20 |
-0.49 |
3,039.00 |
1,575.00 |
47,931.89 |
| Ajanta Pharma Ltd |
3,519.45 |
-0.72 |
3,796.95 |
2,335.00 |
44,299.85 |
| Caplin Point Laboratories Ltd |
2,529.00 |
0.40 |
2,700.00 |
1,502.45 |
19,147.35 |
| ERIS Lifesciences Ltd |
1,316.20 |
0.57 |
1,819.25 |
1,237.90 |
18,136.40 |
|
|
|
|